X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (263) 263
Publication (33) 33
Book Chapter (16) 16
Patent (7) 7
Book / eBook (5) 5
Book Review (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (153) 153
female (78) 78
male (66) 66
endocrinology & metabolism (65) 65
adult (56) 56
middle aged (55) 55
index medicus (43) 43
aged (42) 42
thyroid neoplasms - genetics (41) 41
animals (38) 38
adolescent (34) 34
surgery (30) 30
cancer (27) 27
carcinoma, medullary - genetics (26) 26
oncology (26) 26
mice (24) 24
mutation (24) 24
calcitonin - genetics (22) 22
child (21) 21
retrospective studies (20) 20
thyroid neoplasms - pathology (20) 20
base sequence (19) 19
multiple endocrine neoplasia type 2a - genetics (19) 19
molecular sequence data (18) 18
receptor protein-tyrosine kinases - genetics (18) 18
aged, 80 and over (17) 17
management (17) 17
proto-oncogene proteins c-ret (17) 17
thyroid cancer (17) 17
calcitonin (16) 16
calcitonin gene-related peptide - genetics (16) 16
phenotype (16) 16
proto-oncogene proteins - genetics (16) 16
ret protooncogene (16) 16
risk factors (16) 16
carcinoma (14) 14
cell biology (14) 14
multiple endocrine neoplasia (14) 14
osteoporosis (14) 14
pheochromocytoma - genetics (14) 14
disease (13) 13
expression (13) 13
point mutation (13) 13
proto-oncogene proteins c-ret - genetics (13) 13
thyroid neoplasms - metabolism (13) 13
care and treatment (12) 12
diagnosis (12) 12
drosophila proteins (12) 12
exons (12) 12
germ-line mutation (12) 12
medullary-thyroid carcinoma (12) 12
thyroid neoplasms - diagnosis (12) 12
treatment outcome (12) 12
tumor cells, cultured (12) 12
abridged index medicus (11) 11
metastasis (11) 11
pedigree (11) 11
thyroidectomy (11) 11
adrenal gland neoplasms - genetics (10) 10
biochemistry & molecular biology (10) 10
genetic aspects (10) 10
hela cells (10) 10
medicine, general & internal (10) 10
medullary thyroid carcinoma (10) 10
mice, knockout (10) 10
mutations (10) 10
peptides (10) 10
polymerase chain reaction (10) 10
rats (10) 10
tumors (10) 10
antineoplastic agents - adverse effects (9) 9
biochemistry (9) 9
calcitonin - blood (9) 9
endocrine neoplasia type-2 (9) 9
genotype (9) 9
medicine & public health (9) 9
neoplasm metastasis (9) 9
research (9) 9
survival (9) 9
therapy (9) 9
thyroid neoplasms - surgery (9) 9
thyroid neoplasms - therapy (9) 9
young adult (9) 9
alternative splicing (8) 8
carcinoma - genetics (8) 8
carcinoma, medullary - pathology (8) 8
cell line (8) 8
dna mutational analysis (8) 8
gene (8) 8
genetic testing (8) 8
genetics & heredity (8) 8
health aspects (8) 8
hypercalcemia (8) 8
nucleotides (8) 8
pheochromocytoma (8) 8
protooncogene (8) 8
reoperation (8) 8
risk (8) 8
united states (8) 8
agriculture (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1994, Volume 23, no. 1., xvii, 233
Book
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 5262 - 5262
Journal Article
Thyroid, ISSN 1050-7256, 06/2015, Volume 25, Issue 6, pp. 567 - 610
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 767 - 772
Purpose There is no effective therapy for patients with distant metastasis of medullary thyroid carcinoma (MTC). Activating mutations in the RET proto-oncogene... 
MALIGNANT-TUMORS | ANGIOGENESIS | ONCOLOGY | GROWTH | MUTATIONS | INHIBITOR | CARCINOMA | EXPRESSION | RET PROTOONCOGENE | ZD6474 | KINASES | Carcinoembryonic Antigen - blood | United States | Humans | Middle Aged | Carcinoma, Medullary - metabolism | Male | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Young Adult | Carcinoma, Medullary - drug therapy | Carcinoma, Medullary - secondary | Time Factors | Antineoplastic Agents - adverse effects | Germ-Line Mutation | Adult | Female | Quinazolines - administration & dosage | France | Proto-Oncogene Proteins c-ret - antagonists & inhibitors | Calcitonin - blood | Genetic Predisposition to Disease | Piperidines - administration & dosage | Thyroid Neoplasms - mortality | Carcinoma, Medullary - mortality | Drug Administration Schedule | Administration, Oral | Carcinoma, Medullary - genetics | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Biomarkers, Tumor - blood | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Thyroid Neoplasms - genetics | Thyroid Neoplasms - drug therapy | Pedigree | Piperidines - adverse effects | Quinazolines - adverse effects | Aged | Proto-Oncogene Proteins c-ret - genetics | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | Index Medicus | Hnc7 | Original Reports | Endo7 | To8
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 2426 - 2426
Journal Article
Endocrine Reviews, ISSN 0163-769X, 08/2010, Volume 31, Issue 4, pp. 578 - 599
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 07/2015, Volume 100, Issue 7, pp. 2532 - 2535
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 10/2007, Volume 22, Issue 10, pp. 1479 - 1491
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 06/2008, Volume 23, Issue 6, pp. 826 - 836
Journal Article
Journal of Clinical Endocrinology and Metabolism, ISSN 0021-972X, 03/2017, Volume 102, Issue 3, pp. 933 - 941
Context: Medullary thyroid cancer (MTC) is an aggressive tumor that harbors activating mutations of the RET proto-oncogene. We previously reported that RET... 
APOPTOSIS | ONCOGENE | 2A MUTATION | ENDOCRINOLOGY & METABOLISM | RECEPTOR | CARCINOMA | PROTOONCOGENE | TRANSGENIC MICE | CELL-DEATH | Immunohistochemistry | Proto-Oncogene Proteins c-ret - metabolism | Apoptosis - drug effects | Humans | Middle Aged | Cell Survival - genetics | Apoptosis - genetics | Male | Young Adult | Ubiquitination - drug effects | HEK293 Cells | Aged, 80 and over | Adult | Female | Indoles - pharmacology | Thyroid Gland - cytology | Genes, Tumor Suppressor | Real-Time Polymerase Chain Reaction | Thyroid Gland - drug effects | Carcinoma, Neuroendocrine - metabolism | Cell Survival - drug effects | Cell Proliferation - genetics | Kaplan-Meier Estimate | Activating Transcription Factor 4 - genetics | Carcinoma, Neuroendocrine - genetics | Blotting, Western | Mice, Knockout | Thyroid Neoplasms - genetics | Pyrroles - pharmacology | Animals | Activating Transcription Factor 4 - metabolism | Adolescent | Anilides - pharmacology | Aged | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Thyroid Gland - metabolism | Ubiquitination - genetics | Thyroid Neoplasms - metabolism | Prognosis | Transcription | Hyperplasia | AKT protein | Thyroid gland | Gene deletion | Kinases | Western blotting | Degradation | Proteins | Ubiquitination | Ret protein | Clonal deletion | Deletion | Protein-tyrosine kinase | Thyroid | Expression vectors | Tyrosine | Cell survival | Activating transcription factor 4 | Extracellular signal-regulated kinase | Patients | Survival | Signaling | Thyroid cancer | Cell death | Medical prognosis | Tumor suppressor genes | Mutation | Cellular stress response | Tumors | Cancer | Apoptosis
Journal Article